NO177266C - Analogifremgangsmåte for fremstilling av terapeutisk aktive substituerte azoler - Google Patents

Analogifremgangsmåte for fremstilling av terapeutisk aktive substituerte azoler

Info

Publication number: NO177266C
Authority: NO; Norway
Prior art keywords: preparation; therapeutically active; analogous process; active substituted; substituted azoles
Prior art date: 1990-04-04

Application number

NO911302A

Other languages

English (en)

Norwegian (no)

Other versions

NO911302D0 (no

NO911302L (no

NO177266B (no

Inventor

Adalbert Wagner

Rainer Henning

Hermann Gerhards

Bernward Scholkens

Original Assignee

Hoechst Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1990-04-04

Filing date

1991-04-03

Publication date

1995-08-16

1991-04-03 Application filed by Hoechst Ag filed Critical Hoechst Ag

1991-04-03 Publication of NO911302D0 publication Critical patent/NO911302D0/no

1991-10-07 Publication of NO911302L publication Critical patent/NO911302L/no

1995-01-12 Priority to NO950118A priority Critical patent/NO179705C/no

1995-05-08 Publication of NO177266B publication Critical patent/NO177266B/no

1995-08-16 Publication of NO177266C publication Critical patent/NO177266C/no

Links

150000003851 azoles Chemical class 0.000 title 1
150000001875 compounds Chemical class 0.000 abstract 2
239000000203 mixture Substances 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Pain & Pain Management (AREA)
Rheumatology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Coloring (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Detergent Compositions (AREA)
Cephalosporin Compounds (AREA)
Pyrrole Compounds (AREA)

NO911302A 1990-04-04 1991-04-03 Analogifremgangsmåte for fremstilling av terapeutisk aktive substituerte azoler NO177266C (no)

Priority Applications (1)

Application Number	Priority Date	Filing Date	Title
NO950118A NO179705C (no)	1990-04-04	1995-01-12	Nye azolderivater

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
DE4010797A DE4010797A1 (de)	1990-04-04	1990-04-04	Substituierte azole, verfahren zu deren herstellung, diese enthaltende mittel und deren verwendung

Publications (4)

Publication Number	Publication Date
NO911302D0 NO911302D0 (no)	1991-04-03
NO911302L NO911302L (no)	1991-10-07
NO177266B NO177266B (no)	1995-05-08
NO177266C true NO177266C (no)	1995-08-16

Family

ID=6403704

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO911302A NO177266C (no)	1990-04-04	1991-04-03	Analogifremgangsmåte for fremstilling av terapeutisk aktive substituerte azoler

Country Status (25)

Country	Link
US (2)	US5350751A (cs)
EP (1)	EP0450566B1 (cs)
JP (1)	JP3212036B2 (cs)
KR (1)	KR910018376A (cs)
CN (2)	CN1031940C (cs)
AT (1)	ATE124696T1 (cs)
AU (2)	AU644857B2 (cs)
CA (1)	CA2039622A1 (cs)
CZ (1)	CZ280248B6 (cs)
DE (2)	DE4010797A1 (cs)
DK (1)	DK0450566T3 (cs)
ES (1)	ES2076395T3 (cs)
FI (1)	FI911584A7 (cs)
HU (2)	HU213096B (cs)
IE (1)	IE67790B1 (cs)
IL (1)	IL97760A (cs)
MA (1)	MA22112A1 (cs)
MX (1)	MX25204A (cs)
MY (1)	MY109937A (cs)
NO (1)	NO177266C (cs)
NZ (2)	NZ237644A (cs)
PT (1)	PT97254B (cs)
RU (2)	RU2060255C1 (cs)
SK (1)	SK278797B6 (cs)
ZA (1)	ZA912458B (cs)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE4010797A1 (de) *	1990-04-04	1991-10-10	Hoechst Ag	Substituierte azole, verfahren zu deren herstellung, diese enthaltende mittel und deren verwendung
DE4023215A1 (de) *	1990-07-21	1992-01-23	Hoechst Ag	Substituierte azole, verfahren zu deren herstellung, sie enthaltende mittel und deren verwendung
US5374615A (en) *	1990-10-31	1994-12-20	E. R. Squibb & Sons, Inc.	Indole- and benzimidazole-substituted imidazole and benzimidazole derivatives
PH31175A (en) *	1990-10-31	1998-03-20	Squibb & Sons Inc	Indole and benzimi-dazole-substituted imidazole and benzimidazole derivatives.
DE4036706A1 (de) *	1990-11-17	1992-05-21	Hoechst Ag	Verfahren zur behandlung der cardialen sowie der vasculaeren hypertrophie und hyperplasie
CA2058198A1 (en) *	1991-01-04	1992-07-05	Adalbert Wagner	Azole derivatives, process for their preparation, and their use
TW197428B (cs)	1991-01-04	1993-01-01	Hoechst Ag
CA2061159A1 (en) *	1991-02-26	1992-08-27	Michael A. Poss	Imidazole and benzimidazole derivatives
GB9108811D0 (en) *	1991-04-24	1991-06-12	Erba Carlo Spa	N-imidazolyl derivatives of substituted indole
TW215434B (cs) *	1992-03-07	1993-11-01	Hoechst Ag
US5364869A (en) *	1992-03-09	1994-11-15	Abbott Laboratories	Heterocycle-substituted benzyaminopyridine angiotensin II receptor antagonists
RU2103262C1 (ru) *	1992-07-16	1998-01-27	Лонца АГ Гампель/Валлис	Способ получения 2-замещенных 5-хлоримидазол-4-карбальдегидов
EP0614889A1 (de) *	1993-03-12	1994-09-14	Lonza Ag	Verfahren zur Herstellung von gegebenenfalls 2-substituierten 5-Chlorimidazol-4-carbaldehyden
US5442075A (en) *	1993-03-12	1995-08-15	Lonza Ltd.	Process for the production of 2-substituted 5-chlorimidazole-4-carbaldehydes
US5338740A (en) *	1993-07-13	1994-08-16	Pfizer Inc.	Angiotensin II receptor antagonists
US6011029A (en) *	1996-02-26	2000-01-04	Bristol-Myers Squibb Company	Inhibitors of farnesyl protein transferase
GB9725953D0 (en) *	1997-12-08	1998-02-04	Pfizer Ltd	Compounds useful in therapy
DE19802969A1 (de)	1998-01-27	1999-07-29	Hoechst Marion Roussel De Gmbh	Verfahren zur Herstellung von S-Alkyl(Aryl)-substituierten Imidazol-Derivaten
SE9903028D0 (sv)	1999-08-27	1999-08-27	Astra Ab	New use
GB0008269D0 (en) *	2000-04-05	2000-05-24	Astrazeneca Ab	Combination chemotherapy
DE10019714A1 (de) *	2000-04-20	2002-01-10	Gruenenthal Gmbh	Salze von bicyclischen, N-acylierten Imidazo-3-aminen und Imidazo-5-aminen
PL370270A1 (en) *	2001-11-23	2005-05-16	Solvay Pharmaceuticals Gmbh	Hypertonia treatment during the acute phase of a cerebrovascular accident
US7005432B2 (en) *	2002-05-16	2006-02-28	Hoffman-La Roche Inc.	Substituted imidazol-pyridazine derivatives
ITTO20030140U1 (it) *	2003-09-16	2005-03-17	Interfila Srl	Matita cosmetica
CA2580584C (en) *	2003-09-19	2015-07-28	Galileo Pharmaceuticals, Inc.	Use of alpha-tocotrienol for treatment of mitochondrial diseases
SI1999114T1 (sl)	2006-03-22	2015-10-30	F. Hoffmann-La Roche Ag	Pirazoli kot 11-beta-hsd-1
MX2009013293A (es)	2007-06-04	2010-02-15	Synergy Pharmaceuticals Inc	Agonistas de guanilato ciclasa útiles para el tratamiento de trastornos gastrointestinales, inflamación, cáncer y otros trastornos.
US8969514B2 (en)	2007-06-04	2015-03-03	Synergy Pharmaceuticals, Inc.	Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
EP2810951B1 (en)	2008-06-04	2017-03-15	Synergy Pharmaceuticals Inc.	Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
CA2730603C (en)	2008-07-16	2019-09-24	Synergy Pharmaceuticals Inc.	Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
JP2013506624A (ja) *	2009-09-23	2013-02-28	アミラファーマシューティカルズ，インク．	５−リポキシゲナーゼのインドリジンインヒビター
EP2480547A4 (en) *	2009-09-23	2013-02-20	Panmira Pharmaceuticals Llc	INDOLIZINE INHIBITORS OF 5-LIPOXYGENASE
CN110483499A (zh)	2009-11-05	2019-11-22	圣母大学	咪唑并[1,2-a]吡啶类化合物及其合成及使用方法
US9616097B2 (en)	2010-09-15	2017-04-11	Synergy Pharmaceuticals, Inc.	Formulations of guanylate cyclase C agonists and methods of use
JP2016514671A (ja)	2013-03-15	2016-05-23	シナジーファーマシューティカルズインコーポレイテッド	グアニル酸シクラーゼのアゴニストおよびその使用
JP2016514670A (ja)	2013-03-15	2016-05-23	シナジーファーマシューティカルズインコーポレイテッド	他の薬物と組み合わせたグアニル酸シクラーゼ受容体アゴニスト
EA201592263A1 (ru)	2013-06-05	2016-05-31	Синерджи Фармасьютикалз, Инк.	Ультрачистые агонисты гуанилатциклазы c, способ их получения и использования
US10919888B2 (en)	2015-09-17	2021-02-16	University Of Notre Dame Du Lac	Benzyl amine-containing heterocyclic compounds and compositions useful against mycobacterial infection
EP3886854A4 (en)	2018-11-30	2022-07-06	Nuvation Bio Inc.	Pyrrole and pyrazole compounds and methods of use thereof

Family Cites Families (51)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AT44957B (de) *	1907-12-24	1910-11-10	Charles Henri Perrin	Apparat zum Filtrieren von Flüssigkeiten.
AT53390B (de) *	1908-10-15	1912-05-10	Elek Sche Ind Ges	Kühleinrichtung für gekapselte elektrische Maschinen.
CH443777A (de) *	1965-08-06	1968-02-15	Agripat Sa	Verfahren zum Schützen textiler Keratinfasern vor Insektenfrass und Mittel zur Durchführung dieses Verfahrens
US4182769A (en) *	1977-02-09	1980-01-08	E. I. Du Pont De Nemours And Company	Anti-inflammatory 1-substituted-4,5-diaryl-2-(substituted-thio) imidazoles and their corresponding sulfoxides and sulfones
US4695577A (en) *	1979-08-14	1987-09-22	University Of Miami	Anti-hypertensive agents
US4690940A (en) *	1979-08-14	1987-09-01	University Of Miami	Anti-hypertensive agents
ZA794723B (en) *	1978-09-11	1980-08-27	Univ Miami	Anti-hypertensive agents
US4698356A (en) *	1979-08-14	1987-10-06	University Of Miami	Anti-hypertensive agents
US4690938A (en) *	1979-08-14	1987-09-01	University Of Miami	Anti-hypertensive agents
US4698355A (en) *	1979-08-14	1987-10-06	University Of Miami	Anti-hypertensive agents
US4690939A (en) *	1979-08-14	1987-09-01	University Of Miami	Anti-hypertensive agents
US4690937A (en) *	1979-08-14	1987-09-01	University Of Miami	Anti-hypertensive agents
AU538665B2 (en) *	1979-10-30	1984-08-23	Juridical Foundation, Japanese Foundation For Cancer Research	Human interferon dna
JPS5671074A (en) *	1979-11-12	1981-06-13	Takeda Chem Ind Ltd	1,2-disubstituted-4-halogenoimidazole-5-acetic acid derivative
ZA81219B (en) *	1980-01-23	1982-01-27	Schering Corp	Imidazo (1,2-a) pyridines ,process for their preparation and pharmaceutical compositions containing them
PT70158A1 (en) *	1980-03-03	1982-03-01	Univ Miami	Process for preparing anti-hypertensive agents
US4734420A (en) *	1980-03-05	1988-03-29	University Of Miami	Anti-hypertensive agents
DE3161915D1 (en) *	1980-03-05	1984-02-23	Univ Miami	Angiotensin converting enzyme inhibitors
US4692458A (en) *	1980-03-05	1987-09-08	University Of Miami	Anti-hypertensive agents
US4833152A (en) *	1980-03-05	1989-05-23	University Of Miami	Anti-hypertensive agents
US4690936A (en) *	1980-03-05	1987-09-01	University Of Miami	Anti-hypertensive agents
US4352808A (en) *	1980-12-12	1982-10-05	Schering Corporation	3-Aralkyloxy-2,3-dihydro-2-(imidazolylmethyl)benzo(b)thiophenes and related derivatives, their use as antimicrobials and pharmaceutical formulations useful therefore
US4507294A (en) *	1982-03-08	1985-03-26	Schering Corp.	Imidazo[1,2-a]pyrazines
EP0068378B1 (en) *	1981-06-26	1986-03-05	Schering Corporation	Novel imidazo(1,2-a)pyridines and pyrazines, processes for their preparation and pharmaceutical compositions containing them
US4436746A (en) *	1982-09-30	1984-03-13	Ciba-Geigy Corporation	Thromboxane synthetase inhibitory N-substituted-2-(1-imidazolyl)indoles
US4539410A (en) *	1982-09-30	1985-09-03	Ciba-Geigy Corporation	N-Substituted-2-(1-imidazolyl)indoles
US4695578A (en) *	1984-01-25	1987-09-22	Glaxo Group Limited	1,2,3,9-tetrahydro-3-imidazol-1-ylmethyl-4H-carbazol-4-ones, composition containing them, and method of using them to treat neuronal 5HT function disturbances
US4695579A (en) *	1984-12-21	1987-09-22	Schering Corporation	Antifungal 2-azolylmethyl-3-difluorobenzyloxy-2,3-dihydrofluoro-benzo(B) thiophens
GB8518742D0 (en) *	1985-07-24	1985-08-29	Glaxo Group Ltd	Process
GB8518741D0 (en) *	1985-07-24	1985-08-29	Glaxo Group Ltd	Process
US4731364A (en) *	1985-08-12	1988-03-15	Schering Corporation	Dihydrobenzo(B)thiophenes and pharmaceutical compositions thereof useful as antifungals
US4684654A (en)	1985-08-14	1987-08-04	American Cyanamid Company	3-heteroalkyl-2,4-quinzaolinediones
US4710502A (en)	1985-11-04	1987-12-01	American Cyanamid Company	3-heteroarylalkyl-4-quinazolinones
CA1334092C (en) *	1986-07-11	1995-01-24	David John Carini	Angiotensin ii receptor blocking imidazoles
NZ221996A (en) *	1986-10-07	1989-08-29	Yamanouchi Pharma Co Ltd	Imidazo-pyridine derivatives and pharmaceutical compositions
AU7928787A (en) *	1986-10-07	1988-04-14	Yamanouchi Pharmaceutical Co., Ltd.	Imidazopyridine derivatives
GB8630759D0 (en) *	1986-12-23	1987-02-04	Janssen Pharmaceutica Nv	Carboxylic acid derivatives
NZ224714A (en) *	1987-06-01	1990-03-27	Janssen Pharmaceutica Nv	Substituted benzotriazole derivatives and pharmaceutical compositions
US4943574A (en) *	1987-06-01	1990-07-24	Janssen Pharmaceutica N.V.	(1H-azol-1-ylmethyl) substituted benzotriazole derivatives and pharmaceutical compositions containing them
US4859691A (en) *	1987-07-08	1989-08-22	Ciba-Geigy Corporation	Certain 1,2-benzisoxazole derivatives
US4957931A (en) *	1987-07-08	1990-09-18	Ciba-Geigy Corporation	Certain 1,2-benzisoxazole and 1,2-benzisothiazole derivatives
GB8724912D0 (en) *	1987-10-23	1987-11-25	Wellcome Found	Indole derivatives
CA1338238C (en) *	1988-01-07	1996-04-09	David John Carini	Angiotensin ii receptor blocking imidazoles and combinations thereof with diuretics and nsaids
US5015651A (en) *	1988-01-07	1991-05-14	E. I. Du Pont De Nemours And Company	Treatment of hypertension with 1,2,4-angiotensin II antagonists
JP2614756B2 (ja) *	1988-08-10	1997-05-28	日本ケミファ株式会社	イミダゾール誘導体およびその製造法ならびにこれを含有する抗潰瘍剤
US4977174A (en) *	1989-06-12	1990-12-11	E. R. Squibb & Sons, Inc.	7-oxabicycloheptane imidazole prostaglandin analogs useful in the treatment of thrombotic and vasospastic disease
EP0409332A3 (en) *	1989-07-19	1991-08-07	Merck & Co. Inc.	Substituted triazoles as angiotensin ii antagonists
US5183810A (en) *	1990-02-13	1993-02-02	Merck & Co., Inc.	Imidazole angiotensin II antagonists incorporating a substituted benzyl element
DE4010797A1 (de) *	1990-04-04	1991-10-10	Hoechst Ag	Substituierte azole, verfahren zu deren herstellung, diese enthaltende mittel und deren verwendung
DE4023215A1 (de) *	1990-07-21	1992-01-23	Hoechst Ag	Substituierte azole, verfahren zu deren herstellung, sie enthaltende mittel und deren verwendung
TW215434B (cs) *	1992-03-07	1993-11-01	Hoechst Ag

1990
- 1990-04-04 DE DE4010797A patent/DE4010797A1/de not_active Withdrawn
1991
- 1991-03-28 NZ NZ237644A patent/NZ237644A/en unknown
- 1991-03-28 NZ NZ260561A patent/NZ260561A/xx unknown
- 1991-04-02 US US07/679,233 patent/US5350751A/en not_active Expired - Lifetime
- 1991-04-02 FI FI911584A patent/FI911584A7/fi unknown
- 1991-04-02 CZ CS91906A patent/CZ280248B6/cs not_active IP Right Cessation
- 1991-04-02 SK SK906-91A patent/SK278797B6/sk unknown
- 1991-04-02 EP EP91105178A patent/EP0450566B1/de not_active Expired - Lifetime
- 1991-04-02 AT AT91105178T patent/ATE124696T1/de not_active IP Right Cessation
- 1991-04-02 MY MYPI91000552A patent/MY109937A/en unknown
- 1991-04-02 DE DE59105897T patent/DE59105897D1/de not_active Expired - Lifetime
- 1991-04-02 ES ES91105178T patent/ES2076395T3/es not_active Expired - Lifetime
- 1991-04-02 DK DK91105178.7T patent/DK0450566T3/da active
- 1991-04-03 CA CA002039622A patent/CA2039622A1/en not_active Abandoned
- 1991-04-03 IE IE109891A patent/IE67790B1/en not_active IP Right Cessation
- 1991-04-03 JP JP09611991A patent/JP3212036B2/ja not_active Expired - Lifetime
- 1991-04-03 RU SU914894882A patent/RU2060255C1/ru active
- 1991-04-03 ZA ZA912458A patent/ZA912458B/xx unknown
- 1991-04-03 CN CN91102043A patent/CN1031940C/zh not_active Expired - Fee Related
- 1991-04-03 MX MX2520491A patent/MX25204A/es unknown
- 1991-04-03 AU AU74013/91A patent/AU644857B2/en not_active Ceased
- 1991-04-03 IL IL97760A patent/IL97760A/xx not_active IP Right Cessation
- 1991-04-03 NO NO911302A patent/NO177266C/no unknown
- 1991-04-04 MA MA22381A patent/MA22112A1/fr unknown
- 1991-04-04 HU HU911091A patent/HU213096B/hu not_active IP Right Cessation
- 1991-04-04 KR KR1019910005416A patent/KR910018376A/ko not_active Abandoned
- 1991-04-04 PT PT97254A patent/PT97254B/pt not_active IP Right Cessation
1993
- 1993-12-21 AU AU52560/93A patent/AU658781B2/en not_active Ceased
1994
- 1994-05-27 US US08/250,491 patent/US5440046A/en not_active Expired - Lifetime
- 1994-10-22 CN CN94117640A patent/CN1036263C/zh not_active Expired - Fee Related
1995
- 1995-05-30 RU RU9595108590A patent/RU2092482C1/ru active
- 1995-06-28 HU HU95P/P00507P patent/HU211464A9/hu unknown

Also Published As

Publication number	Publication date
JP3212036B2 (ja)	2001-09-25
NO911302D0 (no)	1991-04-03
IL97760A0 (en)	1992-06-21
MA22112A1 (fr)	1991-12-31
DK0450566T3 (da)	1995-10-30
HUT60734A (en)	1992-10-28
HU213096B (en)	1997-02-28
CZ280248B6 (cs)	1995-12-13
AU5256093A (en)	1994-02-24
RU2092482C1 (ru)	1997-10-10
EP0450566B1 (de)	1995-07-05
IE67790B1 (en)	1996-04-17
CS9100906A2 (en)	1991-11-12
FI911584A0 (fi)	1991-04-02
HU211464A9 (en)	1995-11-28
CN1055361A (zh)	1991-10-16
JPH04234876A (ja)	1992-08-24
IE911098A1 (en)	1991-10-09
DE59105897D1 (de)	1995-08-10
AU658781B2 (en)	1995-04-27
NZ237644A (en)	1994-12-22
NZ260561A (en)	1995-01-27
ES2076395T3 (es)	1995-11-01
RU2060255C1 (ru)	1996-05-20
SK278797B6 (sk)	1998-03-04
FI911584L (fi)	1991-10-05
CN1031940C (zh)	1996-06-05
MX25204A (es)	1993-08-01
RU95108590A (ru)	1997-03-20
AU7401391A (en)	1991-10-10
FI911584A7 (fi)	1991-10-05
HU911091D0 (en)	1991-10-28
NO911302L (no)	1991-10-07
MY109937A (en)	1997-10-31
CN1036263C (zh)	1997-10-29
KR910018376A (ko)	1991-11-30
ATE124696T1 (de)	1995-07-15
US5350751A (en)	1994-09-27
PT97254A (pt)	1992-01-31
AU644857B2 (en)	1993-12-23
DE4010797A1 (de)	1991-10-10
CN1105993A (zh)	1995-08-02
IL97760A (en)	1997-06-10
PT97254B (pt)	1998-07-31
ZA912458B (en)	1991-12-24
CA2039622A1 (en)	1991-10-05
NO177266B (no)	1995-05-08
EP0450566A1 (de)	1991-10-09
US5440046A (en)	1995-08-08

Publication	Publication Date	Title
AU658781B2 (en)	1995-04-27	Substituted azoles and processes for the preparation thereof
DE3365772D1 (en)	1986-10-09	1,4-dihydropyridines, process for their preparation and their application as pharmaceutical preparations
DK599785A (da)	1986-06-22	Blokpolyestere og detergentkompositioner indeholdende disse
SE8404019D0 (sv)	1984-08-08	Oftalmiskt medel
FI823923L (fi)	1983-05-18	Antifibrinolytiskt aktiva foereningar
NO180083C (no)	1997-02-12	Fremstilling av substituerte piperidiner
FI933903A0 (fi)	1993-09-07	Substituerade cyklohexanderivat, foerfarande foer framstaellning daerav och anvaendning av foereningar foer behandling av sjukdomar
FI853622A0 (fi)	1985-09-20	Diarylacetylener, deras framstaellning och anvaendning.
DK0393424T3 (da)	1996-02-05	Fremgangsmåde til fremstilling af 2,7-diazabicyclo(3.3.0)octaner
DK0457090T3 (da)	1996-04-15	Fremgangsmåde til fremstilling af 3-amino-2-(het)-aroyl-acrylsyrederivater
DE3564684D1 (en)	1988-10-06	Tetrahydrothienopyridines, process for their preparation and their pharmaceutical application
FR2611713B1 (fr)	1990-11-30	Nouveaux derives de l'acide (dihydro-2,3 oxo-2 benzofurannyl-3)-2 acetique, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent
SE9203824D0 (sv)	1992-12-18	Benzofuranylimidazole derivatives a process for the preparation and therapeutical compositions containing the same
DK0552631T3 (da)	1998-05-11	Alfa-Aryl-alfa-hydroxy-beta-imidazolinyl-propionsyreamider
ATE89555T1 (de)	1993-06-15	3-substituierte 1-(2-halogen-alkoxybenzolsulfonyl)-3-heteroaryl-harnstoffe.